Parkinson's - The Bright Side

The Bright Side

Sign in Subscribe

Parkinson's

A collection of 2 posts

The FDA Approved a Once-Daily Parkinson's Pill Called Juvmo

The FDA Approved a Once-Daily Parkinson's Pill Called Juvmo

The FDA approved Juvmo, a once-daily D1/D5 pill for Parkinson's. In TEMPO-3 it added 1.7 hours of on-time versus 0.6 on placebo. It is not a cure.

Parkinson's Patients Show Sustained Benefits from Personalized Stem Cell Therapy

Health & Medicine

Parkinson's Patients Show Sustained Benefits from Personalized Stem Cell Therapy

Parkinson's Patients Show Sustained Benefits from Personalized Stem Cell Therapy 12-month trial data reveals promising results with no serious side effects for autologous treatment Parkinson's patients in a groundbreaking clinical trial are showing sustained improvements in motor function and quality of life 12 months after receiving